Switch to:
Also traded in: Germany, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.44
SYK's Cash to Debt is ranked lower than
76% of the 326 Companies
in the Global Medical Devices industry.

( Industry Median: 2.32 vs. SYK: 0.44 )
Ranked among companies with meaningful Cash to Debt only.
SYK' s Cash to Debt Range Over the Past 10 Years
Min: 0.04  Med: 1.86 Max: 164.16
Current: 0.44
0.04
164.16
Equity to Asset 0.46
SYK's Equity to Asset is ranked lower than
72% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. SYK: 0.46 )
Ranked among companies with meaningful Equity to Asset only.
SYK' s Equity to Asset Range Over the Past 10 Years
Min: 0.22  Med: 0.62 Max: 0.78
Current: 0.46
0.22
0.78
Interest Coverage N/A
SYK's Interest Coverage is ranked higher than
72% of the 221 Companies
in the Global Medical Devices industry.

( Industry Median: 73.78 vs. SYK: N/A )
Ranked among companies with meaningful Interest Coverage only.
SYK' s Interest Coverage Range Over the Past 10 Years
Min: 24.67  Med: N/A Max: No Debt
Current: N/A
F-Score: 8
Z-Score: 4.02
M-Score: -2.25
WACC vs ROIC
5.86%
17.63%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 19.78
SYK's Operating margin (%) is ranked higher than
89% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 2.42 vs. SYK: 19.78 )
Ranked among companies with meaningful Operating margin (%) only.
SYK' s Operating margin (%) Range Over the Past 10 Years
Min: 12.88  Med: 20.48 Max: 23.93
Current: 19.78
12.88
23.93
Net-margin (%) 15.24
SYK's Net-margin (%) is ranked higher than
86% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 1.87 vs. SYK: 15.24 )
Ranked among companies with meaningful Net-margin (%) only.
SYK' s Net-margin (%) Range Over the Past 10 Years
Min: 5.32  Med: 15.65 Max: 17.4
Current: 15.24
5.32
17.4
ROE (%) 18.75
SYK's ROE (%) is ranked higher than
87% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 1.47 vs. SYK: 18.75 )
Ranked among companies with meaningful ROE (%) only.
SYK' s ROE (%) Range Over the Past 10 Years
Min: 5.84  Med: 18.28 Max: 21.28
Current: 18.75
5.84
21.28
ROA (%) 8.96
SYK's ROA (%) is ranked higher than
82% of the 330 Companies
in the Global Medical Devices industry.

( Industry Median: 0.20 vs. SYK: 8.96 )
Ranked among companies with meaningful ROA (%) only.
SYK' s ROA (%) Range Over the Past 10 Years
Min: 3.08  Med: 12.16 Max: 15.38
Current: 8.96
3.08
15.38
ROC (Joel Greenblatt) (%) 76.45
SYK's ROC (Joel Greenblatt) (%) is ranked higher than
91% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 3.44 vs. SYK: 76.45 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
SYK' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 43.65  Med: 67.6 Max: 85.29
Current: 76.45
43.65
85.29
Revenue Growth (3Y)(%) 4.90
SYK's Revenue Growth (3Y)(%) is ranked higher than
54% of the 233 Companies
in the Global Medical Devices industry.

( Industry Median: 3.90 vs. SYK: 4.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
SYK' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 4.9  Med: 11.4 Max: 32.9
Current: 4.9
4.9
32.9
EBITDA Growth (3Y)(%) 4.00
SYK's EBITDA Growth (3Y)(%) is ranked higher than
50% of the 195 Companies
in the Global Medical Devices industry.

( Industry Median: 4.00 vs. SYK: 4.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
SYK' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -9.1  Med: 13.7 Max: 59.8
Current: 4
-9.1
59.8
EPS Growth (3Y)(%) 3.70
SYK's EPS Growth (3Y)(%) is ranked higher than
53% of the 196 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. SYK: 3.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
SYK' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -42.6  Med: 16.6 Max: 153
Current: 3.7
-42.6
153
» SYK's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

SYK Guru Trades in Q4 2015

Jim Simons 26,100 sh (New)
Ray Dalio 12,164 sh (New)
Pioneer Investments 26,932 sh (New)
Paul Tudor Jones 207,500 sh (+2666.67%)
Vanguard Health Care Fund 2,498,900 sh (+74.32%)
Robert Olstein 52,000 sh (+6.12%)
Diamond Hill Capital 936,985 sh (+1.46%)
PRIMECAP Management 295,500 sh (unchged)
Yacktman Focused Fund Sold Out
John Hussman Sold Out
Dodge & Cox Sold Out
Louis Moore Bacon Sold Out
Jeremy Grantham 1,467,369 sh (-13.22%)
Yacktman Fund 1,700,000 sh (-15.00%)
Donald Yacktman 2,061,165 sh (-34.44%)
Steven Cohen 18,800 sh (-92.64%)
» More
Q1 2016

SYK Guru Trades in Q1 2016

Murray Stahl 2,000 sh (New)
Joel Greenblatt 85,828 sh (New)
George Soros 20,300 sh (New)
Pioneer Investments 37,559 sh (+39.46%)
Vanguard Health Care Fund 2,498,900 sh (unchged)
PRIMECAP Management 295,500 sh (unchged)
Ray Dalio Sold Out
Jim Simons Sold Out
Steven Cohen Sold Out
Diamond Hill Capital 917,488 sh (-2.08%)
Donald Yacktman 1,948,574 sh (-5.46%)
Yacktman Fund 1,600,000 sh (-5.88%)
Jeremy Grantham 1,287,095 sh (-12.29%)
Robert Olstein 45,000 sh (-13.46%)
Paul Tudor Jones 4,200 sh (-97.98%)
» More
Q2 2016

SYK Guru Trades in Q2 2016

Pioneer Investments 43,865 sh (+16.79%)
Jeremy Grantham 1,321,268 sh (+2.66%)
Vanguard Health Care Fund 2,498,900 sh (unchged)
PRIMECAP Management 295,500 sh (unchged)
Murray Stahl 2,000 sh (unchged)
George Soros Sold Out
Diamond Hill Capital 883,282 sh (-3.73%)
Paul Tudor Jones 3,700 sh (-11.90%)
Robert Olstein 38,000 sh (-15.56%)
Joel Greenblatt 63,965 sh (-25.47%)
Donald Yacktman 1,402,704 sh (-28.01%)
Yacktman Fund 1,100,000 sh (-31.25%)
» More
Q3 2016

SYK Guru Trades in Q3 2016

Louis Moore Bacon 4,820 sh (New)
Jeremy Grantham 1,385,768 sh (+4.88%)
Murray Stahl 2,000 sh (unchged)
Joel Greenblatt Sold Out
Pioneer Investments 42,064 sh (-4.11%)
Diamond Hill Capital 843,629 sh (-4.49%)
Yacktman Fund 1,000,000 sh (-9.09%)
Donald Yacktman 1,264,330 sh (-9.86%)
Paul Tudor Jones 3,200 sh (-13.51%)
Vanguard Health Care Fund 2,159,500 sh (-13.58%)
Robert Olstein 32,000 sh (-15.79%)
PRIMECAP Management 228,400 sh (-22.71%)
» More
» Details

Insider Trades

Latest Guru Trades with SYK

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339112    SIC: 3842
Compare:NYSE:BSX, NYSE:ABT, NAS:ISRG, NYSE:STJ, NYSE:ZBH, NYSE:EW, OTCPK:SNNUF, NYSE:VAR, OTCPK:SONVY, NAS:ALGN, NYSE:TFX, OTCPK:CHEOY, NAS:ABMD, OTCPK:EKTAY, NAS:NUVA, NAS:IART, NAS:MASI, NAS:LIVN, NYSE:NVRO, NAS:WMGI » details
Traded in other countries:SYK.Germany, SYK.Switzerland, 0R2S.UK,
Stryker Corporation is a medical technology company. The Company offers medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products.

Stryker Corp was incorporated in Michigan in 1946. It is a medical technology company. The Company offers medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products. Its business segments are Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics products consist of implants used in hip and knee joint replacements and trauma and extremities surgeries. The Company supports surgeons with the technology and services needed as the company develops new surgical techniques. The MedSurg products include surgical equipment and surgical navigation systems (Instruments); endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (Medical); and reprocessed and remanufactured medical devices (Sustainability) as well as other medical device products used in a variety of medical specialties. The Neurotechnology and Spine products include both neurosurgical and neurovascular devices. Its neurotechnology offering includes products used for minimally invasive endovascular techniques; a comprehensive line of products for traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. It also develops, manufacture and market spinal implant products including cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. The Company's competitors include Zimmer Biomet Holdings, Inc. (Zimmer), DePuy Synthes (companies of Johnson & Johnson) and Smith & Nephew plc (Smith & Nephew). The Company's businesses are subject to varying degrees of governmental regulation in the countries in which the company operates and the general trend is toward increasingly stringent regulation.

Top Ranked Articles about Stryker Corp

Answers to the Hardest Question: When Do I Sell a Stock? There are 2 primary reasons it makes sense to sell a stock
The most common complaint I have heard from investors over my 40-plus years in the financial services industry is as follows: "Everyone wants to tell me what to buy and when, but no one ever tells me when to sell." Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 26.59
SYK's P/E(ttm) is ranked lower than
51% of the 172 Companies
in the Global Medical Devices industry.

( Industry Median: 25.16 vs. SYK: 26.59 )
Ranked among companies with meaningful P/E(ttm) only.
SYK' s P/E(ttm) Range Over the Past 10 Years
Min: 11.3  Med: 24.99 Max: 71.37
Current: 26.59
11.3
71.37
Forward P/E 18.28
SYK's Forward P/E is ranked higher than
74% of the 54 Companies
in the Global Medical Devices industry.

( Industry Median: 21.74 vs. SYK: 18.28 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 26.59
SYK's PE(NRI) is ranked higher than
51% of the 172 Companies
in the Global Medical Devices industry.

( Industry Median: 25.53 vs. SYK: 26.59 )
Ranked among companies with meaningful PE(NRI) only.
SYK' s PE(NRI) Range Over the Past 10 Years
Min: 11.3  Med: 25.21 Max: 71.37
Current: 26.59
11.3
71.37
Price/Owner Earnings (ttm) 34.33
SYK's Price/Owner Earnings (ttm) is ranked lower than
52% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 30.39 vs. SYK: 34.33 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
SYK' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 12.61  Med: 20.95 Max: 216.58
Current: 34.33
12.61
216.58
P/B 4.63
SYK's P/B is ranked lower than
65% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 3.08 vs. SYK: 4.63 )
Ranked among companies with meaningful P/B only.
SYK' s P/B Range Over the Past 10 Years
Min: 2.19  Med: 3.43 Max: 6.24
Current: 4.63
2.19
6.24
P/S 4.03
SYK's P/S is ranked lower than
61% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 3.02 vs. SYK: 4.03 )
Ranked among companies with meaningful P/S only.
SYK' s P/S Range Over the Past 10 Years
Min: 1.94  Med: 3.35 Max: 5.29
Current: 4.03
1.94
5.29
PFCF 31.52
SYK's PFCF is ranked lower than
58% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 26.13 vs. SYK: 31.52 )
Ranked among companies with meaningful PFCF only.
SYK' s PFCF Range Over the Past 10 Years
Min: 11.77  Med: 19.94 Max: 111.1
Current: 31.52
11.77
111.1
POCF 24.15
SYK's POCF is ranked lower than
65% of the 134 Companies
in the Global Medical Devices industry.

( Industry Median: 18.20 vs. SYK: 24.15 )
Ranked among companies with meaningful POCF only.
SYK' s POCF Range Over the Past 10 Years
Min: 10.32  Med: 17.1 Max: 58.83
Current: 24.15
10.32
58.83
EV-to-EBIT 22.13
SYK's EV-to-EBIT is ranked higher than
51% of the 169 Companies
in the Global Medical Devices industry.

( Industry Median: 21.46 vs. SYK: 22.13 )
Ranked among companies with meaningful EV-to-EBIT only.
SYK' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.8  Med: 15 Max: 35.3
Current: 22.13
6.8
35.3
EV-to-EBITDA 17.90
SYK's EV-to-EBITDA is ranked lower than
54% of the 182 Companies
in the Global Medical Devices industry.

( Industry Median: 16.23 vs. SYK: 17.90 )
Ranked among companies with meaningful EV-to-EBITDA only.
SYK' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.5  Med: 12.4 Max: 25.6
Current: 17.9
5.5
25.6
Shiller P/E 37.09
SYK's Shiller P/E is ranked higher than
59% of the 49 Companies
in the Global Medical Devices industry.

( Industry Median: 46.10 vs. SYK: 37.09 )
Ranked among companies with meaningful Shiller P/E only.
SYK' s Shiller P/E Range Over the Past 10 Years
Min: 20.27  Med: 30.13 Max: 71.26
Current: 37.09
20.27
71.26
Current Ratio 2.43
SYK's Current Ratio is ranked higher than
50% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 2.43 vs. SYK: 2.43 )
Ranked among companies with meaningful Current Ratio only.
SYK' s Current Ratio Range Over the Past 10 Years
Min: 1.61  Med: 2.51 Max: 5.37
Current: 2.43
1.61
5.37
Quick Ratio 1.74
SYK's Quick Ratio is ranked lower than
52% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 1.82 vs. SYK: 1.74 )
Ranked among companies with meaningful Quick Ratio only.
SYK' s Quick Ratio Range Over the Past 10 Years
Min: 0.98  Med: 2.08 Max: 4.63
Current: 1.74
0.98
4.63
Days Inventory 182.86
SYK's Days Inventory is ranked lower than
69% of the 290 Companies
in the Global Medical Devices industry.

( Industry Median: 134.83 vs. SYK: 182.86 )
Ranked among companies with meaningful Days Inventory only.
SYK' s Days Inventory Range Over the Past 10 Years
Min: 140.11  Med: 159.05 Max: 182.86
Current: 182.86
140.11
182.86
Days Sales Outstanding 60.47
SYK's Days Sales Outstanding is ranked higher than
61% of the 277 Companies
in the Global Medical Devices industry.

( Industry Median: 66.89 vs. SYK: 60.47 )
Ranked among companies with meaningful Days Sales Outstanding only.
SYK' s Days Sales Outstanding Range Over the Past 10 Years
Min: 59.31  Med: 61.46 Max: 62.7
Current: 60.47
59.31
62.7
Days Payable 41.95
SYK's Days Payable is ranked lower than
64% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 57.49 vs. SYK: 41.95 )
Ranked among companies with meaningful Days Payable only.
SYK' s Days Payable Range Over the Past 10 Years
Min: 33.46  Med: 44.78 Max: 55.97
Current: 41.95
33.46
55.97

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.30
SYK's Dividend Yield is ranked lower than
60% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 1.73 vs. SYK: 1.30 )
Ranked among companies with meaningful Dividend Yield only.
SYK' s Dividend Yield Range Over the Past 10 Years
Min: 0.21  Med: 1.21 Max: 1.66
Current: 1.3
0.21
1.66
Dividend Payout 0.35
SYK's Dividend Payout is ranked higher than
82% of the 119 Companies
in the Global Medical Devices industry.

( Industry Median: 0.39 vs. SYK: 0.35 )
Ranked among companies with meaningful Dividend Payout only.
SYK' s Dividend Payout Range Over the Past 10 Years
Min: 0.18  Med: 0.28 Max: 1.91
Current: 0.35
0.18
1.91
Dividend Growth (3y) 16.20
SYK's Dividend Growth (3y) is ranked higher than
68% of the 76 Companies
in the Global Medical Devices industry.

( Industry Median: 9.10 vs. SYK: 16.20 )
Ranked among companies with meaningful Dividend Growth (3y) only.
SYK' s Dividend Growth (3y) Range Over the Past 10 Years
Min: -12  Med: 21.6 Max: 81.9
Current: 16.2
-12
81.9
Forward Dividend Yield 1.30
SYK's Forward Dividend Yield is ranked lower than
66% of the 181 Companies
in the Global Medical Devices industry.

( Industry Median: 1.77 vs. SYK: 1.30 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 3.00
SYK's Yield on cost (5-Year) is ranked higher than
69% of the 221 Companies
in the Global Medical Devices industry.

( Industry Median: 1.73 vs. SYK: 3.00 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
SYK' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.48  Med: 2.77 Max: 3.8
Current: 3
0.48
3.8
3-Year Average Share Buyback Ratio 0.60
SYK's 3-Year Average Share Buyback Ratio is ranked higher than
88% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. SYK: 0.60 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SYK' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -0.8  Med: -0.1 Max: 1.9
Current: 0.6
-0.8
1.9

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 2.10
SYK's Price/Projected FCF is ranked lower than
52% of the 124 Companies
in the Global Medical Devices industry.

( Industry Median: 1.97 vs. SYK: 2.10 )
Ranked among companies with meaningful Price/Projected FCF only.
SYK' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.92  Med: 1.83 Max: 99.06
Current: 2.1
0.92
99.06
Price/Median PS Value 1.21
SYK's Price/Median PS Value is ranked lower than
59% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: 1.02 vs. SYK: 1.21 )
Ranked among companies with meaningful Price/Median PS Value only.
SYK' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.63  Med: 1.11 Max: 1.71
Current: 1.21
0.63
1.71
Earnings Yield (Greenblatt) (%) 4.58
SYK's Earnings Yield (Greenblatt) (%) is ranked higher than
74% of the 315 Companies
in the Global Medical Devices industry.

( Industry Median: 0.90 vs. SYK: 4.58 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
SYK' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2.8  Med: 6.7 Max: 14.6
Current: 4.58
2.8
14.6
Forward Rate of Return (Yacktman) (%) 5.54
SYK's Forward Rate of Return (Yacktman) (%) is ranked lower than
58% of the 121 Companies
in the Global Medical Devices industry.

( Industry Median: 9.23 vs. SYK: 5.54 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
SYK' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -3.9  Med: 12.6 Max: 28.1
Current: 5.54
-3.9
28.1

More Statistics

Revenue (TTM) (Mil) $10,883
EPS (TTM) $ 4.39
Beta0.54
Short Percentage of Float2.25%
52-Week Range $86.68 - 123.55
Shares Outstanding (Mil)374.45

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 11,267 12,162 12,899
EPS ($) 5.75 6.41 6.95
EPS w/o NRI ($) 5.75 6.41 6.95
EPS Growth Rate
(3Y to 5Y Estimate)
8.76%
Dividends Per Share ($) 1.41 1.49 1.89
» More Articles for SYK

Headlines

Articles On GuruFocus.com
6 Stocks That Beat the Market Oct 05 2016 
Healthcare Winners: Stryker Corp., UnitedHealth Group Inc. Aug 29 2016 
Johnson & Johnson Reports 4% Sales Growth for the Second Quarter Jul 22 2016 
Becton Dickinson: 19% EPS Growth With Good Dividends Jun 26 2016 
Answers to the Hardest Question: When Do I Sell a Stock? Jun 23 2016 
Weekly Insider Sells: Medivation, JPMorgan Chase, Stryker, Sabre Jan 26 2016 
Stryker: An Expensive Growth Play Dec 26 2015 
Louis Moore Bacon's Largest 3rd Quarter Trades Dec 23 2015 
Eric Mindich Sells Stakes in Catamaran and Alphabet in 3rd Quarter Dec 02 2015 
Weekly Insider Sells Highlights: Nike, Intuitive Surgical, Travelers Companies, Stryker Oct 26 2015 

More From Other Websites
O’Leary: Regional banks are dangerous Dec 09 2016
Stryker CEO: Medical tax is a 'job and innovation killer' Dec 09 2016
Stryker increases 2017 annual dividend by 12% and declares a $0.425 per share quarterly dividend Dec 07 2016
Top Research Reports for Amazon, Ford & Dow Chemical Dec 05 2016
4 Merrill Lynch Med Tech and Drug Dividend Stocks to Buy With Huge 2017 Potential Dec 05 2016
ETFs with exposure to Stryker Corp. : December 1, 2016 Dec 01 2016
Stryker Corp. breached its 50 day moving average in a Bullish Manner : SYK-US : November 30, 2016 Nov 30 2016
Hedge Funds Are Buying Stryker Corporation (SYK) Nov 28 2016
Analyzing Stryker’s Latest Valuation Nov 22 2016
Here's Why Stryker Stock Will Continue to Rise Nov 22 2016
Exploring SYK’s MAKO Robot Performance and Future Expectations Nov 22 2016
Where Is Stryker’s Leading Orthopedics Business Segment Headed? Nov 22 2016
Exploring the Nuances of Stryker’s Cost Transformation for Growth Nov 21 2016
How Is Stryker Moving Forward with International Growth? Nov 21 2016
How Are Stryker’s Core Strategies Working Toward Its Growth? Nov 21 2016
How Will the US Election’s Results Impact Stryker’s Business? Nov 18 2016
What Are Analysts’ Latest Recommendations for Stryker? Nov 18 2016
Stryker-IUIH Medicity Program to Deliver Services in India Nov 16 2016
Stryker announces multi-year partnership with Indo UK Institute of Health to deliver affordable... Nov 14 2016
Two Companies Witness Insider Selling after Releasing Strong Results, Plus Insider Buying at Three... Nov 08 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)